Skip to main content
. 2015 Sep 17;113(7):996–1002. doi: 10.1038/bjc.2015.239

Figure 2.

Figure 2

BCSS and DFS according to the proliferation group. BCSS, breast cancer-specific survival; DFS, disease-free survival; HR, hazard ratio; MI, mitotic index. (A) For BCSS, HR discrepant group=4.35 (2.06–9.21; P=0.0001). HR ‘high MI/high Ki67' group=9.77 (4.80–19.89; P<0.0001). (B) For DFS, HR discrepant group=2.49 (1.64–3.76; P<0.0001). HR ‘high MI/high Ki67' group=4.97 (3.32–7.43; P<0.0001).